Literature DB >> 27660057

Associations of cytochrome P450 oxidoreductase genetic polymorphisms with smoking cessation in a Chinese population.

Huijie Li1, Suyun Li1, Qiang Wang1, Chongqi Jia2.   

Abstract

Recently, a single nucleotide polymorphism (SNP) A503V (rs1057868) in cytochrome P450 oxidoreductase (POR) gene was reported to influence nicotine metabolism. Considering the importance of nicotine metabolism to smoking cessation, the aim of this study was to investigate the association between POR gene polymorphisms and smoking cessation in a Chinese population. A case-control study was conducted with 363 successful smoking quitters as the cases, and 345 failed smoking quitters as the controls. Eight tagSNPs which cover the entire gene and four functional SNPs were selected and genotyped. Logistic regression was used to explore the relationship between POR SNPs and smoking cessation in codominant, additive, dominant and recessive models. After adjustment for potential confounders, multiple logistic regression analysis indicated that POR rs3823884 and rs3898649 were associated with increased possibility of smoking cessation. Meanwhile, POR rs17685 and rs239953 were shown to have negative effect on successful smoking cessation. No significant differences in the distribution of haplotypes between cases and controls were detected. In conclusion, this study reveals that four SNPs in the POR gene (rs3823884, rs3898649, rs239953 and rs17685) may affect the susceptibility of smoking cessation in a Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27660057     DOI: 10.1007/s00439-016-1728-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  55 in total

1.  Consequences of POR mutations and polymorphisms.

Authors:  Walter L Miller; Vishal Agrawal; Duanpen Sandee; Meng Kian Tee; Ningwu Huang; Ji Ha Choi; Kari Morrissey; Kathleen M Giacomini
Journal:  Mol Cell Endocrinol       Date:  2010-11-09       Impact factor: 4.102

2.  Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations.

Authors:  Ningwu Huang; Vishal Agrawal; Kathleen M Giacomini; Walter L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

3.  Variation in P450 oxidoreductase (POR) A503V and flavin-containing monooxygenase (FMO)-3 E158K is associated with minor alterations in nicotine metabolism, but does not alter cigarette consumption.

Authors:  Meghan J Chenoweth; Andy Z X Zhu; Lisa Sanderson Cox; Jasjit S Ahluwalia; Neal L Benowitz; Rachel F Tyndale
Journal:  Pharmacogenet Genomics       Date:  2014-03       Impact factor: 2.089

4.  Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis.

Authors:  Ningwu Huang; Amit V Pandey; Vishal Agrawal; William Reardon; Pablo D Lapunzina; David Mowat; Ethylin Wang Jabs; Guy Van Vliet; Joseph Sack; Christa E Flück; Walter L Miller
Journal:  Am J Hum Genet       Date:  2005-03-25       Impact factor: 11.025

Review 5.  Minireview: regulation of steroidogenesis by electron transfer.

Authors:  Walter L Miller
Journal:  Endocrinology       Date:  2005-03-17       Impact factor: 4.736

6.  Trends in smoking and quitting in China from 1993 to 2003: National Health Service Survey data.

Authors:  Juncheng Qian; Min Cai; Jun Gao; Shenglan Tang; Ling Xu; Julia Alison Critchley
Journal:  Bull World Health Organ       Date:  2010-04-16       Impact factor: 9.408

7.  Effects of the CYP oxidoreductase Ala503Val polymorphism on CYP3A activity in vivo: a randomized, open-label, crossover study in healthy Chinese men.

Authors:  Guoping Yang; Zhimin Fu; Xiaoping Chen; Hong Yuan; Heng Yang; Yuanyuan Huang; Dongsheng Ouyang; Zhirong Tan; Hongyi Tan; Zhijun Huang; Honghao Zhou
Journal:  Clin Ther       Date:  2011-12       Impact factor: 3.393

Review 8.  Molecular genetics of nicotine metabolism.

Authors:  Jill C Mwenifumbo; Rachel F Tyndale
Journal:  Handb Exp Pharmacol       Date:  2009

Review 9.  Pharmacogenetics of P450 oxidoreductase: implications in drug metabolism and therapy.

Authors:  Lei Hu; Wei Zhuo; Yi-Jing He; Hong-Hao Zhou; Lan Fan
Journal:  Pharmacogenet Genomics       Date:  2012-11       Impact factor: 2.089

10.  Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation.

Authors:  Ana M Gomes; Stefan Winter; Kathrin Klein; Miia Turpeinen; Elke Schaeffeler; Matthias Schwab; Ulrich M Zanger
Journal:  Pharmacogenomics       Date:  2009-04       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.